Rapt Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $391k | 16k | 24.85 |
| 2023-09-30 | $262k | 16k | 16.62 |
| 2023-06-30 | $295k | 16k | 18.70 |
| 2023-03-31 | $289k | 16k | 18.35 |
| 2022-12-31 | $273k | 14k | 19.80 |
| 2022-09-30 | $332k | 14k | 24.06 |
| 2022-06-30 | $236k | 13k | 18.25 |
| 2022-03-31 | $243k | 11k | 21.99 |
| 2021-12-31 | $256k | 7.0k | 36.73 |
| 2021-09-30 | $216k | 7.0k | 31.04 |
| 2021-06-30 | $221k | 7.0k | 31.76 |
| 2020-09-30 | $172k | 5.3k | 32.20 |
| 2020-06-30 | $155k | 5.3k | 29.02 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors